Skip to main content
. 1999 Mar;67(3):1317–1322. doi: 10.1128/iai.67.3.1317-1322.1999

FIG. 4.

FIG. 4

Dot immunoblot detection of the CPS-500 epitope recognized by MAb 18.44 before (lane 1) and after treatment with mixed α-glycosidases (lane 3), mixed β-glycosidases (lane 4), β-d-glucosidase (lane 5), β-d-xylosidase (lane 6), or β-d-mannosidase (lane 7). Lane 2 contains untreated CPS-500 probed with an isotype control MAb. Serial twofold dilutions of CPS-500 are dotted from top to bottom.